These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38843684)

  • 1. Autophagy mediated targeting degradation, a promising strategy in drug development.
    Zhang J; Pan X; Ji W; Zhou J
    Bioorg Chem; 2024 Aug; 149():107466. PubMed ID: 38843684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the undruggables-the power of protein degraders.
    Zhang C; Liu Y; Li G; Yang Z; Han C; Sun X; Sheng C; Ding K; Rao Y
    Sci Bull (Beijing); 2024 Jun; 69(11):1776-1797. PubMed ID: 38614856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging degrader technologies engaging lysosomal pathways.
    Ding Y; Xing D; Fei Y; Lu B
    Chem Soc Rev; 2022 Oct; 51(21):8832-8876. PubMed ID: 36218065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancing targeted protein degradation for metabolic diseases therapy.
    Zhou QQ; Xiao HT; Yang F; Wang YD; Li P; Zheng ZG
    Pharmacol Res; 2023 Feb; 188():106627. PubMed ID: 36566001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Protein Degradation via Lysosomes.
    Paudel RR; Lu D; Roy Chowdhury S; Monroy EY; Wang J
    Biochemistry; 2023 Feb; 62(3):564-579. PubMed ID: 36130224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera).
    Ji CH; Lee MJ; Kim HY; Heo AJ; Park DY; Kim YK; Kim BY; Kwon YT
    Autophagy; 2022 Sep; 18(9):2259-2262. PubMed ID: 35722947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted degradation of ⍺-synuclein aggregates in Parkinson's disease using the AUTOTAC technology.
    Lee J; Sung KW; Bae EJ; Yoon D; Kim D; Lee JS; Park DH; Park DY; Mun SR; Kwon SC; Kim HY; Min JO; Lee SJ; Suh YH; Kwon YT
    Mol Neurodegener; 2023 Jun; 18(1):41. PubMed ID: 37355598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protein induced proximity and targeted degradations by new degraders: concepts, developments, challenges for clinical applications].
    Reboud-Ravaux M
    Biol Aujourdhui; 2024; 218(1-2):41-54. PubMed ID: 39007776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to targeted protein degradation technologies in drug discovery.
    Xue Y; Bolinger AA; Zhou J
    Expert Opin Drug Discov; 2023 Apr; 18(4):467-483. PubMed ID: 36895136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome system.
    Ji CH; Kim HY; Lee MJ; Heo AJ; Park DY; Lim S; Shin S; Ganipisetti S; Yang WS; Jung CA; Kim KY; Jeong EH; Park SH; Bin Kim S; Lee SJ; Na JE; Kang JI; Chi HM; Kim HT; Kim YK; Kim BY; Kwon YT
    Nat Commun; 2022 Feb; 13(1):904. PubMed ID: 35173167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the Scope of Targeted Protein Degradation: Translational Opportunities in Hijacking the Autophagy-Lysosome Pathway.
    Cassidy K; Zhao H
    Biochemistry; 2023 Feb; 62(3):580-587. PubMed ID: 34569233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifaceted targeted protein degradation systems for different cellular compartments.
    Zorca CE; Fallahi A; Luo S; Eldeeb MA
    Bioessays; 2022 Jun; 44(6):e2200008. PubMed ID: 35417040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches for small molecule-induced protein degradation.
    Wu S; Xiao H; Sun Q
    Future Med Chem; 2021 Mar; 13(5):439-441. PubMed ID: 33438469
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioorthogonal Aptamer-ATTEC Conjugates for Degradation of Alpha-Synuclein via Autophagy-Lysosomal Pathway.
    Liao X; Qin G; Liu Z; Ren J; Qu X
    Small; 2024 Feb; 20(8):e2306760. PubMed ID: 37821404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AUTACs: Cargo-Specific Degraders Using Selective Autophagy.
    Takahashi D; Moriyama J; Nakamura T; Miki E; Takahashi E; Sato A; Akaike T; Itto-Nakama K; Arimoto H
    Mol Cell; 2019 Dec; 76(5):797-810.e10. PubMed ID: 31606272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and Challenges in Targeted Protein Degradation for Neurodegenerative Disease Therapy.
    Fang Y; Wang J; Zhao M; Zheng Q; Ren C; Wang Y; Zhang J
    J Med Chem; 2022 Sep; 65(17):11454-11477. PubMed ID: 36006861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research.
    Li X; Liu Q; Xie X; Peng C; Pang Q; Liu B; Han B
    J Med Chem; 2023 Feb; 66(3):1700-1711. PubMed ID: 36716420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs.
    Alabi SB; Crews CM
    J Biol Chem; 2021; 296():100647. PubMed ID: 33839157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents.
    Coll-Martínez B; Delgado A; Crosas B
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33339292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting selective autophagy by AUTAC degraders.
    Takahashi D; Arimoto H
    Autophagy; 2020 Apr; 16(4):765-766. PubMed ID: 31958028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.